📍 Jagiellonian University, Kraków, Poland
🗓️ Application Deadline (First Call): 30 June 2025
💰 Salary: ≥ 9370 PLN/month gross (~6700 PLN net); full employment benefits

The MAP-ID (Multilevel Approaches to Understanding Chronic Inflammatory Diseases) program at the Jagiellonian University offers 13 fully funded PhD positions, co-funded by the European Commission under the Horizon Europe MSCA COFUND scheme.

🌍 Program Highlights

• Duration: 48 months (start: 1 October 2025)

• International & intersectoral secondments (Europe & USA + biotech companies)

• Full-time employment with social security, health, and pension benefits

• Monthly employer budget: €2800

• Strong academic-industry network with institutions such as Oxford, KU Leuven, UNLV, and biotech firms like Ryvu Therapeutics & PerioTrap

🔬 Research Projects (selection of 13 topics)

1. Chronic neuroinflammation & glioblastoma – Regnase-2

2. Inflammation’s role in renal/liver cancer

3. Tumor hypoxia, redox & immunotherapy

4. Tissue-specific fibroblasts in inflammation

5. Neuro-immune crosstalk at barrier sites

6. Epigenetic memory in HSC-driven inflammation

7. PIN domain RNases & transcriptome regulation

8. Periodontitis & rheumatoid arthritis connection

9. Chronic bacterial diseases & renal carcinoma

10. TA systems in S. aureus and virulence

11. Stem cell EVs for tissue regeneration

12. Innate immunity receptor mechanisms

13. Small RNAs in wound healing

🌐 Full project details & application:

Website.

✅ Eligibility Criteria

• Master’s in life sciences/medicine by start date

• No PhD or prior PhD defense

• MSCA mobility rule: not resided in Poland >12 months in last 36 months

• English proficiency (min. B2 level)

📝 How to Apply
Applications via the IRK system only.
📅 First call: April 28 – June 30, 2025
📅 Second call (if needed): September 1 – November 2, 2025

📧 Contact: Email

More opportunities link here!